Impact BioMedical Inc.
IBO
$0.6437
-$0.0211-3.17%
AMEX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -38.47M | -25.01M | -24.71M | 1.17M | -4.25M |
Total Depreciation and Amortization | 7.00K | 6.00K | 7.00K | 6.00K | 5.00K |
Total Amortization of Deferred Charges | 1.12M | 1.12M | 1.11M | 1.11M | 1.11M |
Total Other Non-Cash Items | 33.96M | 20.89M | 20.79M | -5.22M | 439.00K |
Change in Net Operating Assets | -534.00K | -603.00K | -608.00K | 352.00K | 717.00K |
Cash from Operations | -3.92M | -3.61M | -3.41M | -2.59M | -1.97M |
Capital Expenditure | -- | -- | -- | 0.00 | -1.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 2.00K | 3.00K | 2.00K | 3.00K | 2.00K |
Cash from Investing | 2.00K | 3.00K | 2.00K | 3.00K | 1.00K |
Total Debt Issued | 811.00K | 1.20M | 1.68M | 1.32M | 1.97M |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 3.73M | 3.73M | 3.73M | 3.73M | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 4.54M | 4.92M | 5.40M | 5.05M | 1.97M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 622.00K | 1.32M | 2.00M | 2.47M | -1.00K |